Document:

Exhibit 10(ccc)

--------------------------------------------------------------------------------
AWARD/CONTRACT     1. THIS CONTRACT IS A RATED ORDER     RATING    PAGE OF PAGES
                      UNDER DPAS (15 CFR 350)                        1      20
--------------------------------------------------------------------------------
2. CONTRACT (Proc. Inst. Ident.) NO.    3. EFFECTIVE DATE
   DAMD17-03-C-0040                                     01 Jan 2003
--------------------------------------------------------------------------------
4. REQUISITION/PURCHASE REQUEST/PROJECT NO.
   W23RYX-2331-N643
--------------------------------------------------------------------------------
5. ISSUED BY             CODE DAMD17    6. ADMINISTERED BY           CODE
                              ----------   (If other than Item 5.)        ------
USA MED RESEARCH ACQ ACTIVITY
DIRECTOR  820 CHANDLER STREET              See Item 5
FORT DETRICK MD 21702-5014

--------------------------------------------------------------------------------
7. NAME AND ADDRESS OF CONTRACTOR       8. DELIVERY
   (No., street, city, country, state      |_| FOB ORIGIN  |X| OTHER (See below)
   and zip code)                        ----------------------------------------
                                        9. DISCOUNT FOR PROMPT PAYMENT
SIGA TECHNOLOGIES INC.
DENNIS E. HRUBY, PH.D.                  Net 30 Days
4575 SW RESEARCH WAY
SUITE 230                               ----------------------------------------
CORVALLIS OR 97333                      10. SUBMIT INVOICES   1   ITEM

                                        (4 copies unless
                                        otherwise specified)          Block 12
----------------------------------------TO THE ADDRESS
CODE 1V4X4               FACILITY CODE  SHOWN IN:
--------------------------------------------------------------------------------
11. SHIP TO/MARK FOR     CODE           12. PAYMENT WILL BE MADE BY  CODE HQ0345
                              ----------                                  ------
USA MED RESEARCH AND MATERIELCOM        DEFENSE FINANCE AND ACCOUNTING SERVICE
ACQUILINE TEST A                        DFAS-SA/FPA  500 MCCULLOUGH AVENUE
COMMANDER USAMRMC  ATTN:MCMR-RMI-S      PHONE: 888-478-5636
BLDG 504XX                              SAN ANTONIO TX 78215-2100
FORT DETRICK MD 21702

--------------------------------------------------------------------------------
13. AUTHORITY FOR USING OTHER THAN      14. ACCOUNTING AND APPROPRIATION DATA
    FULL AND OPEN COMPETITION:
|_| 10 U.S.C. 2304(c)( )                See Schedule
|_| 41 U.S.C. 253(c)( )
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------
15A. ITEM NO.   15B. SUPPLIES/SERVICES   15C. QUANTITY   15D. UNIT   15E. UNIT PRICE   15F. AMOUNT
------------------------------------------------------------------------------------------------------
<S>             <C>                      <C>             <C>         <C>               <C>
                     SEE SCHEDULE

------------------------------------------------------------------------------------------------------
                                                         15G. TOTAL AMOUNT OF CONTRACT   $1,640,883.00
------------------------------------------------------------------------------------------------------
</TABLE>

--------------------------------------------------------------------------------
                             16. TABLE OF CONTENTS
--------------------------------------------------------------------------------
(X)  SEC.                         DESCRIPTION                            PAGE(S)
--------------------------------------------------------------------------------
                              PART 1 - THE SCHEDULE
--------------------------------------------------------------------------------
X     A     SOLICITATION/CONTRACT FORM                                   1
--------------------------------------------------------------------------------
X     B     SUPPLIES OR SERVICES AND PRICES/COSTS                        2
--------------------------------------------------------------------------------
X     C     DESCRIPTION/SPECS./WORK STATEMENT                            3 - 9
--------------------------------------------------------------------------------
      D     PACKAGING AND MARKING
--------------------------------------------------------------------------------
X     E     INSPECTION AND ACCEPTANCE                                    10
--------------------------------------------------------------------------------
X     F     DELIVERIES OR PERFORMANCE                                    11 - 15
--------------------------------------------------------------------------------
X     G     CONTRACT ADMINISTRATION DATA                                 16 - 17
--------------------------------------------------------------------------------
      H     SPECIAL CONTRACT REQUIREMENTS
--------------------------------------------------------------------------------
                           PART II - CONTRACT CLAUSES
--------------------------------------------------------------------------------
X     I     CONTRACT CLAUSES                                             18 - 20
--------------------------------------------------------------------------------
          PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACHMENTS
--------------------------------------------------------------------------------
      J     LIST OF ATTACHMENTS
--------------------------------------------------------------------------------
                   PART IV - REPRESENTATIONS AND INSTRUCTIONS
--------------------------------------------------------------------------------
      K     REPRESENTATIONS, CERTIFICATIONS AND
            OTHER STATEMENTS OF OFFERORS
--------------------------------------------------------------------------------
      L     INSTRS., CONDS., AND NOTICES TO OFFERORS
--------------------------------------------------------------------------------
      M     EVALUATION FACTORS FOR AWARD
--------------------------------------------------------------------------------
         CONTRACTING OFFICER WILL COMPLETE ITEM 17 OR 18 AS APPLICABLE
--------------------------------------------------------------------------------
17. |_| CONTRACTOR'S NEGOTIATED AGREEMENT Contractor is required to sign this
document and return   copies to issuing office.) Contractor agrees to furnish
and deliver all items or perform all the services set forth or otherwise
identified above and on any continuation sheets for the consideration stated
herein. The rights and obligations of the parties to this contract shall be
subject to and governed by the following documents: (a) this award/contract,
(b) the solicitation, if any, and (c) such provisions, representations,
certifications, and specifications, as are attached or incorporated by reference
herein.
(Attachments are listed herein.)
--------------------------------------------------------------------------------
18. |_| AWARD  (Contractor is not required to sign this document.) Your offer
on Solicitation Number ________________ including the additions or changes made
by you which additions or changes are set forth in full above, is hereby
accepted as to the items listed above and on any continuation sheets. This award
consummates the contract which consists of the following documents: (a) the
Government's solicitation and your offer, and (b) this award/contract. No
further contractual document is necessary.
--------------------------------------------------------------------------------
19A. NAME AND TITLE OF SIGNER           20A. NAME AND TITLE OF CONTRACTING
     (Type or print)                         OFFICER
                                        PATRICIA K. NELSON/CONTRACTING OFFICER
                                        TEL: 301-619-2702
                                        EMAIL: patricia.nelson@amedd.army.mi
--------------------------------------------------------------------------------
19B. NAME OF CONTRACTOR                 19C. DATE SIGNED

BY _____________________________________
(Signature of person authorized to sign)
--------------------------------------------------------------------------------
20B. UNITED STATES OF AMERICA           20C. DATE SIGNED

BY /s/ Patricia K. Nelson                    12-Dec-2002
  --------------------------------------
  (Signature of Contracting Officer)
--------------------------------------------------------------------------------
NSN 7540-01-152-8069                 26-107         STANDARD FORM 26 (REV. 4-85)

PREVIOUS EDITION UNUSABLE    GPO 1985 O - 469-794   Prescribed by GSA
                                                    FAR (48 CFR) 53.214(a)
<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 2 of 20

        Section B - Supplies or Services and Prices

ITEM NO SUPPLIES/SERVICES       QUANTITY        UNIT    UNIT PRICE      AMOUNT

001

        COST
        Research Proposal entitled, "SmallPox Antiviral Drug"
        PURCHASE REQUEST NUMBER:  W23RYX-2331-N643

                                                ESTIMATED COST     $1,640,883.00
        ACRN AA Funded Amount                                        $364,642.00

   FOB: Destination

<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 3 of 20

Section C - Description and Specifications

STATEMENT OF WORK
The contractor shall furnish the necessary equipment, personnel, facilities, and
supplies necessary to conduct studies on the research proposal entitled,
"Smallpox AntiViral Drug" in accordance with Section C, the contractor's
statement of work on pages 4-5 of the research proposal dated 15 May 2002 and
the revised budget dated 22 November 2002, which are incorporated herein by
reference.

TERM OF CONTRACT: 1 January 2003-31 May 2007 (Research to be completed by 31
December 2006).

AMOUNT ALLOTTED TO CONTRACT TO DATE: $364,642

TOTAL AMOUNT OF CONTRACT: $1,640,883

PRINCIPAL INVESTIGATOR: Dr. Dennis E. Hruby

TYPE OF CONTRACT: Cost Price Contract

CLAUSES INCORPORATED BY FULL TEXT

REPRESENTATIONS AND CERTIFICATIONS (MAR 1999) (USAMRAA)

The representations, certifications, and other statements submitted by the
contractor, dated 22 November 2002, are incorporated herein by reference.

PRINCIPAL INVESTIGATOR (MAR 1999) (USAMRAA)

The Principal Investigator for this contract is Dennis R. Hruby. This individual
shall be continuously responsible for the conduct of the research project. The
contractor shall obtain the Contracting Officer's approval to change the
Principal Investigator or to continue the research work during a continuous
period in excess of three months without the participation of an approved
Principal Investigator. This contract is based on the Principal Investigator
devoting 10% of effort to the project over the term of the contract. The
contractor shall advise the Contracting Officer if the Principal Investigator
will, or plans to, devote substantially less effort to the work than estimated
in the contractor's proposal. A curriculum vitae shall be provided for
professional associates added to the research project or substituted during the
course of work.

USE OF TECHNICAL REFERENCE FACILITY (MAR 1999) (USAMRAA)

The contractor agrees to use, to the extent practical, the technical reference
facilities of the Defense Technical Information Center, 8725 John J. Kingman
Road, Suite 0944, Fort Belvoir, VA 22060-6218 for the purpose of surveying
existing knowledge and avoiding needless duplication of scientific and
engineering effort and the expenditure thereby represented. All other sources,
whether or not Government controlled, shall be consulted for the same purpose.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 4 of 20

INVESTIGATING AND REPORTING POSSIBLE SCIENTIFIC MISCONDUCT (MAR 1999) (USAMRAA)

a. "Misconduct" or "Misconduct in Science" is defined as fabrication,
falsification, plagiarism, or other practices that seriously deviate from those
that are commonly accepted within the scientific community for proposing,
conducting or reporting research. It does not include honest error or honest
differences in interpretations or judgments of data.
b. Contractors shall foster a research environment that prevents misconduct in
all research and that deals forthrightly with possible misconduct associated
with research for which U.S. Army Medical Research and Materiel Command funds
have been provided or requested.
c. The contractor agrees to:
(1) Establish and keep current an administrative process to review, investigate,
and report allegations of misconduct in science in connection with research
conducted by the contractor,
(2) Comply with its own administrative process;
(3) Inform its scientific and administrative staff of the policies and
procedures and the importance of compliance with those policies and procedures;
(4) Take immediate and appropriate action as soon as misconduct on the part of
employees or persons within the organization's control is suspected or alleged;
and
(5) Report to the Administrative Contracting Officer (ACO) a decision to
initiate an investigation into possible scientific misconduct.
d. The contractor is responsible for notifying the ACO of appropriate action
taken if at any stage of an inquiry or investigation any of the following
conditions exist:
(1) An immediate health hazard is involved;
(2) There is an immediate need to protect Federal funds or equipment;
(3) A probability exists that the alleged incident will be reported publicly; or
(4) There is a reasonable indication of possible criminal violation.

EMERGENCY COORDINATION AND REPORTING (BDRP) (MAR 1999) (USAMRAA)

a. The contractor shall review the Emergency Response Plan/Safety Program Plan
annually, during the month of July, in consultation with each participating
external support agency. The Emergency Response Plan shall be formally revised,
where necessary, to incorporate current emergency support requirements. The
revised Emergency Response Plan (with the agreements for emergency support as
appendices) shall be formalized in writing. A copy of the revision shall be
retained in your organizational safety office.
b. The contractor shall submit a letter report documenting the outcome of the
annual review of its Emergency Response Plan. The report shall include the dates
of the annual review and coordination, and shall identify and describe all
provisions that represent changes to the initial Emergency Response Plan or the
previous year's annual report. The report shall be submitted no later than
August 1 of each year, beginning with the first August during the performance of
your contract.
c. All reports identified in this provision shall be submitted to the following
address:
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-RCQ-S
504 Scott Street
Fort Detrick, Maryland 21702-5012

ETIOLOGIC AGENTS--BIOLOGICAL DEFENSE RESEARCH PROGRAM (MAR 1999) (USAMRAA)

a. For purpose of this contract etiologic agent--biological defense program is
defined as: any viable microorganism, or its toxin which causes or may cause
human disease, including those agents listed in 42 CFR 723 of the Department of
Health and Human Services regulations, and any agent of biological origin that
poses a degree of

<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 5 of 20

hazard to those agents and is further identified by the U.S. Army as a threat
agent. The contractor shall comply with the following when working with
etiologic agents:

1. 29 Code of Federal Regulations 1910

2. Occupational Health Standards, and the U.S. Department of Health and Human
Services (DHHS)

3. DHHS Publication No. 93-8395, Biosafety in Microbiological and Biomedical
Laboratories, 1993, as amended

4. 32 CFR 626 Biological Defense Safety Program

5. 32 CFR 627 Biological Defense Safety Program b. Etiologic agents shall be
packaged, labeled, shipped, and transported in accordance with applicable
Federal, state and local laws and regulations, to include:

1. 42 CFR 72 (Interstate Shipment of Etiologic Agents)

2. 49 CFR 172 and 173 (Department of Transportation)

3. 9 CFR 122 (USDA Restricted Animal Pathogens)

4. International Air Transport Association Dangerous Goods Regulations.

5. The United States Postal Service shall not be used for transportation of BDRP
activities involving etiologic agents.

CONTRACTOR SAFETY AND REPORTING (BDRP) (MAR 1999) (USAMRAA)

a. The contractor shall operate under established safety programs for all
biosafety levels of work as identified in the Safety Program Plan, which is
incorporated in this contract. These safety programs shall ensure that
personnel, facilities, and the environment are protected from accidents and
hazardous exposures.
b. The contractor shall conduct this contract work under established operating
procedures which ensure that all individuals who have access to areas for
storage, handling, and disposal of etiologic agents are trained and are
thoroughly familiar with safety requirements. Such procedures shall assure full
compliance with the regulatory standards cited above.
c. The contractor shall conduct an inspection and report the results of all
required biosafety inspections for all Research, Development, Test, or
Evaluation work in accordance with the below listed timeframes. As a minimum the
safety inspections shall address those factors identified in the Safety Program
Plan.
1. For Biosafety Level (BL) 1 and 2:
Time               Inspector
Preaward             Government designated Biosafety
Officer
Quarterly          First line supervisor
Annual               Contractor safety personnel
2. For Biosafety Level (BL) 3:
Time               Inspector
Preaward             Government designated Biosafety
Officer
Monthly            First line supervisor
Annual               Government designated Bisafety
Officer
3. For Biosafety Level (BL) 4:
Time               Inspector
Preaward             Government designated Biosafety
Officer
Monthly            First line supervisor
Semiannual           Government designated Biosafety
Officer
4. Copies of all biosafety inspection reports will be
<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 6 of 20

distributed as follows:
Original:
In the contractor's records (Retained for at least three years)
One copy to the following:
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-RCQ-S
504 Scott Street
Fort Detrick, Maryland 21702-5012
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-PLD
504 Scott Street
Fort Detrick, Maryland 21702-5012
U.S. Army Medical Research Acquisition Activity
ATTN: MCMR-AAA
820 Chandler Street
Fort Detrick, Maryland 21702-5014

PROHIBITION OF USE OF HUMAN SUBJECTS (NOV 2000) (USAMRAA)

Notwithstanding any other provisions contained in this award or incorporated by
reference herein, the contractor is expressly forbidden to use or subcontract
for the use of human subjects in any manner whatsoever. In the performance of
this award, the contractor agrees not to come into contact with, use or employ,
or subcontract for the use or employ of any human subjects for research,
experimentation, tests or other treatment under the scope of work as set out in
the award

USE OF LABORATORY ANIMALS (CONUS)(MAR 2002) (USAMRAA)

      a. The contractor or its subcontractors, are authorized to conduct
      research under this award involving laboratory animals for the following
      protocols:

      Protocol entitled, "Smallpox Antiviral Drug" submItted by Dr. Dennis Hruby
      for the use of mice,

      b. ANIMAL WELFARE

      (1) For those facilities that are required to do so by federal law, the
contractor shall register its research facility with the Secretary of
Agriculture in accordance with 7 U.S.C. 2136 and 9 CFR, Subchapter A, Part 2,
Subpart C, and Section 2.30.

      (2) The contractor shall acquire regulated animals only from dealers
licensed by the Secretary of Agriculture under 7 U.S.C. 2133 and 9 CFR,
Subchapter A, Part 2, Subpart A, Sections 2.1 through 2.11, or from sources that
are exempt from licensing under those sections.

      (3) The contractor agrees that the care and use of animals will conform

<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 7 of 20

with the pertinent laws of the United States and regulations of the Department
of Agriculture (see 7 U.S.C. 2131 et.seq. and 9 CFR Subchapter A, Parts I
through 4), and that the research will adhere to the principles set forth in the
Guide for Care and Use of Laboratory Animals, National Research Council, 1996.

      (4) The Contracting Officer may immediately suspend, in whole or in part,
work and further payments under this award for failure to comply with the
requirements of paragraphs (1) through (3) of this clause.

            (a) The suspension will stay in effect until the contractor complies
with the requirements.

            (b) Failure to complete corrective action within the time specified
by the Contracting Officer may result in termination of this award and removal
of the contractor's name from the list of facilities approved for funding.

      (5) The contractor may request registration of its facility and a current
listing of licensed dealers from the Regional Office of the Animal and Plant
Health Inspection Service (APHIS), United States Department of Agriculture
(USDA), for the region in which its research facility is located. The location
of the appropriate APHIS regional office, as well as information concerning this
program may be obtained by contacting the Senior Staff Officer, Animal Care
Staff, USDA/APHIS, Animal Care, 4700 River Road, Unit 84, Riverdale, MD
20737-1234 (Phone number 301-734-4981 or email ace@usda.gov).

      (6) The contractor shall include this clause, including this paragraph
(6), in all subcontracts/subawards involving research of live vertebrate
animals.

      c. POST-AWARD OVERSIGHT OF THE USE OF LABORATORY ANIMALS

      Post-award oversight of the use of laboratory animals shall be the
responsibility of the contractor's Animal Care and Use Committee (ACUC). The
Principal Investigator will notify the Contracting Officer in writing of any
significant changes to the proposed use of animals which was the basis for
award. These changes must be approved by the contractor's ACUC and the USAMRMC.
In addition, the ACUC shall immediately notify the Contracting Officer of any
violations of law, or regulation involving animal care, or of changes in the
facility's accreditation status by the Association for the Assessment and
Accreditation of Laboratory Animal Care, International (AAALAC).

      d. ANIMAL USE REPORTING

      (1) The contractor shall annually prepare and electronically submit the
U.S. Army Medical Research and Materiel Command Animal Use Report detailing the
use of animals in the research and development sponsored by the Army. The web
site containing information for electronic submission of this report may be
found at http://www.usamraa.army.mil.

      (2) A letter with additional instructions concerning use of the electronic
web site will be mailed at the end of the fiscal year. The reporting period
shall be each Federal Fiscal Year, i.e., 01 October through 30 September, and
the report shall be electronically received by the U.S. Army Medical Research
and Materiel Command no later than 1 December of that year.

      (3) For awards with expiration dates prior to 30 September, instructions
for submission of the final animal use report may be found at
http://www.usamraa.army.mil.

      (4) The contractor shall also furnish a copy of the most recent USDA
Inspection Report. This report can be submitted via fax or mail to:

<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 8 of 20

                  Commander
                  U.S. Army Medical Research & Materiel Command
                  ATTN: MCMR-RCQ-AR
                  504 Scott Street
                  Fort Detrick MD 21702-5012
                  FAX:  (301) 619-4165

            (5) The contractor is responsible for ensuring that a separate U.S.
Army Medical Research and Materiel Command Animal Use Report and USDA Inspection
Report be submitted for any subcontract/subaward facility).

PROHIBITION OF USE OF HUMAN ANATOMICAL SUBSTANCES (NOV 2000) (USAMRAA)

Notwithstanding any other provisions contained in this award or incorporated by
reference herein, the contractor is expressly forbidden to use or subcontract
for the use of human anatomical substances in any manner whatsoever. In the
performance of this award, the contractor agrees not to come into contact with,
use or employ, or subcontract for the use or employ of any human anatomical
substances for research, experimentation, tests or other treatment under the
scope of work as set out in the award.

REPORTS, MANUSCRIPTS AND PUBLIC RELEASES (MAR 1999) (USAMRAA)

a. Contractors are encouraged to publish results of research supported by
USAMRMC in appropriate media forum. Any publication, report or public release,
which may create a statutory bar to the issuance of a patent on any subject
invention, shall be coordinated with appropriate patent counsel.

b. Manuscripts intended for publication in any media shall be submitted to the
COR, simultaneously with submission for publication. Review of such manuscripts
is for comment to the Principal Investigator, not for approval or disapproval.
Courtesy copies of the reprint shall be forwarded to the COR, even though
publication may be subsequent to the expiration of the contract.

c. The contractor shall notify the Contracting Officer of planned news releases,
planned publicity, advertising material concerning contract work, and planned
presentations to scientific meetings prior to public release. This is not
intended to restrict dissemination of research information but to allow the U.S.
Army Medical Research and Materiel Command (USAMRMC) advance notice in order to
adequately respond to inquiries.

d. Manuscripts, reports, public releases and abstracts, which appear in
professional journals, media and programs, shall include the following
statements:

(1) "This work is supported by the U.S. Army Medical Research and Materiel
 Command under Contract No. DAMD17-03-C-40."
(2) "The views, opinions and/or findings contained in this report are those of
the author(s) and should not be construed as an official Department of the Army
position, policy or decision unless so designated by other documentation."
(3) "In conducting research using animals, the investigator(s) adhered to the
"Guide for the Care and Use of Laboratory Animals," prepared by the Committee on
Care and Use of Laboratory Animals of the Institute of Laboratory Animal
Resources, National Research Council (NIH Publication No. 86-23, Revised 1985)."
(4) "In the conduct of research where humans are the subjects, the
investigator(s) adhered to the policies regarding the protection of human
subjects as prescribed by 45 CFR 46 and 32 CFR 219 (Protection of Human
Subjects)."

<PAGE>

                                                                DAMD17-03-C-0040

                                                                    Page 9 of 20

(5) In conducting work involving the use of recombinant DNA the investigator(s)
adhered to Guidelines for Research Involving Recombinant DNA Molecules; Notice,
Federal Register, July 5, 1994, Volume 59, Number 127.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 10 of 20

Section E - Inspection and Acceptance

CLAUSES INCORPORATED BY REFERENCE

52.246-8          Inspection Of Research And Development Cost   MAY 2001
                  Reimbursement

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 11 of 20

Section F - Deliveries or Performance

PERFORMANCE

      a. The period of performance for this contract is 1 January 2003 through
31 May 2007 (Research ends 31 December 2006). The research required by the
statement of work in Section C shall be conducted during the period 1 Jan 2003
through 31 December 2006. The additional month is to allow sufficient time to
complete the final reports.

CLAUSES INCORPORATED BY REFERENCE

52.242-15         Stop-Work Order             AUG 1989
52.247-34         F.O.B. Destination          NOV 1991

REPORTING REQUIREMENT

QUARTERLY REPORTS FORMAT (OCT 1992) (USAMRAA)

a. Quarterly reports are the most immediate and direct contact between the
Principal Investigator (PI) and the Contracting Officer's Representative (COR).
The reports provide the means for keeping this Command advised of developments
and problems as the contract effort proceeds. The quarterly reports also provide
a measure against which decisions on release of funding and on requests for
supplements are made.

b. Quarterly reports shall be submitted for each three-month period of the
contract beginning with the effective date of the contract. This requirement
includes all three-month periods of the contract.

c. Copies of each report shall be submitted in the quantities indicated to the
addresses shown below within fifteen (15) days after the end of each quarter.
Internal Government distribution will be made by those offices.

     (1) Two (2) copies of the report to:
         U.S.Army Medical Research Institute for Infectious Diseases (USAMRIID)
         ATTN:  Dr. Jay Hooper
         1425 Porter Street
         Fort Detrick, MD 21702

     (2) Three (3) copies of the report to:
         Commander
         U.S. Army Medical Research and Materiel Command
         ATTN:  MCMR-RMI-S
         504 Scott Street
         Fort Detrick, MD 21702-5012

     (3) One (1) copy of the report to:
         Director
         U. S. Army Medical Research Acquisition Activity (USAMRAA)
         ATTN: MCMR-AAA-A
         820 Chandler Street
         Fort Detrick, MD 21702-5014

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 12 of 20

d. Photocopies of the blank Quarterly report sample shown on the following page
shall serve as the format. Each item of the report format shall be completed or
addressed.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 13 of 20

                            Quarterly Report Format

1. Contract No.__________________________ 2. Report Date _________________

3. Reporting period from ________________ to _____________________________

4. PI____________________________________ 5. Telephone No. _______________

6. Institution__________________________________________________________________

7. Project Title: ______________________________________________________________

________________________________________________________________________________

8. Current staff, with percent effort of each on project.

________________________________% _____________________________%

________________________________% _____________________________%

9. Contract expenditures to date (as applicable):

                              This Qtr/Cumulative

Personnel______________________________/_____________________________

Travel_________________________________/_____________________________

Fringe Benefits________________________/_____________________________

Equipment______________________________/_____________________________

Supplies_______________________________/________________ Other__________________

                              This Qtr/Cumulative

Subtotal_______________________________/_____________________________

Indirect Costs_________________________/_____________________________

Fee____________________________________/_____________________________

Total:_________________________________/________________________ ____

10. Comments on administrative and logistical matters.

________________________________________________________________________________

________________________________________________________________________________

________________________________________________________________________________

________________________________________________________________________________

11. Use additional page(s), as necessary, to describe scientific progress for
the quarter in terms of the tasks or objectives listed in the statement of work
for this contract. Explain deviations where this isn't possible. Include data
where possible.

12. Use additional page(s) to present a brief statement of plans or milestones
for the next quarter.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 14 of 20

RESEARCH TECHNICAL REPORTING REQUIREMENTS (NOV 2000) (USAMRAA)

Format Requirements for Annual/Final Reports

      a. Annual reports must provide a complete summary of the research
accomplishments to date with respect to the approved Statement of Work. Journal
articles can be substituted for detailed descriptions of specific aspects of the
research, but the original articles must be attached to the report as an
appendix and appropriately referenced in the text. The importance of the report
to decisions relating to continued support of the research can not be
overemphasized. A report shall be submitted within 30 calendar days of the
anniversary date of the award (a final report will be submitted upon completion
of the research (last year of the award)).

      b. A final report summarizing the entire research effort, citing data in
the annual reports and appended publications shall be submitted at the end of
the award performance period. The final report will provide a complete reporting
of the research findings. Journal publications can be substituted for detailed
descriptions of specific aspects of the research, but an original copy of each
publication must be attached as an appendix and appropriately referenced in the
text. All final reports must include a bibliography of all publications and
meeting abstracts and a list of personnel (not salaries) receiving pay from the
research effort.

      c. Although there is no page limitation for the reports, each report shall
be of sufficient length to provide a thorough description of the accomplishments
with respect to the approved Statement of Work. Submission of an original and
two copies of the report are required. Reports shall be forwarded to:

                  Commander
                  U.S. Army Medical Research and Materiel Command
                  ATTN: MCMR-RMI-S
                  504 Scott Street Fort Detrick,
                  Maryland 21702-5012

      d. All reports shall have the following elements in this order: front
cover, Standard Form (SF 298), table of contents, introduction, body, key
research accomplishments, reportable outcomes, conclusions, references, and
appendices. Pages shall be consecutively numbered throughout the report. DO NOT
RENUMBER PAGES IN THE APPENDICES BUT DO INCLUDE THE APPENDICES IN THE PAGE COUNT
IN BLOCK 15 ON THE SF 298. Mark all pages of the report which contain
proprietary or unpublished data that should be protected. DO NOT USE THE WORD
"CONFIDENTIAL" WHEN MARKING DOCUMENTS. Indicate in your letter accompanying the
report that the report contains proprietary or unpublished data, and that the
distribution statement should indicate the limitations of the report.

FRONT COVER: Sample front cover provided at http://mrmc-www.army.mil. The
Accession Document (AD) Number should remain blank.

STANDARD FORM 298: Sample SF 298 provided at http://mrmc-www.army.mil. Go to
site index and click on Research Reports and click on SF298 for a copy. The
abstract in Block 13 must state the purpose, scope, major findings and be an
up-to-date report of the progress in terms of results and significance. Subject
terms are keywords that may have previously assigned to the proposal abstract or
are keywords that may be significant to the research. The number of pages shall
include all pages that have printed data (including the front cover, SF 298,
table of contents, and all appendices). Please count pages carefully to ensure
legibility and that there are no missing pages as this delays processing of
reports. Page numbers should be typed: please do not hand number pages.

TABLE OF CONTENTS: Sample table of contents provided at
http://mrmc-www.army.mil.

INTRODUCTION: Narrative that briefly (one paragraph) describes the subject,
purpose and scope of the research.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 15 of 20

BODY: This section of the report shall describe the research accomplishments
associated with each task outlined in the approved Statement of Work. Data
presentation shall be comprehensive in providing a complete record of the
research findings for the period of the report. Appended publications and/or
presentations may be substituted for detailed descriptions but must be
referenced in the body of the report. If applicable, for each task outlined in
the Statement of Work, reference appended publications and/or presentations for
details of result findings and tables and/or figures. The report shall include
negative as well as positive findings. Include problems in accomplishing any of
the tasks. Statistical tests of significance shall be applied to all data
whenever possible. Figures and graphs referenced in the text may be embedded in
the text or appended. Figures and graphs can also be referenced in the text and
appended to a publication. Recommended changes or future work to better address
the research topic may also be included, although changes to the original
Statement of Work must be approved by the Grants Officer. This approval must be
obtained prior to initiating any change to the original Statement of Work.

KEY RESEARCH ACCOMPLISHMENTS: Bulleted list of key research accomplishments
emanating from this research.

REPORTABLE OUTCOMES: Provide a list of reportable outcomes that have resulted
from this research to include:

                  manuscripts, abstracts, presentations; patents and
                  licenses applied for and/or issued; degrees obtained
                  that are supported by this award; development of
                  cell lines, tissue or serum repositories; infomatics
                  such as databases and animal models, etc.; funding
                  applied for based on work supported by this award;
                  employment or research opportunities applied for
                  and/or received based on experience/training
                  supported by this award.

CONCLUSIONS: Summarize the results to include the Importance and/or implications
of the completed research and when necessary, recommend changes on future work
to better address the problem. A "so what section" which evaluates the knowledge
as a scientific or medical product shall also be included in the conclusion of
the report.

REFERENCES: List all references pertinent to the report using a standard journal
format (i.e. format used in Science, Military Medicine, etc.).

APPENDICES: Attach all appendices that contain information that supplements,
clarifies or supports the text. Examples include original copies of journal
articles, reprints of manuscripts and abstracts, a curriculum vitae, patent
applications, study questionnaires, and surveys, etc.

BINDING: Because all reports are entered into the Department of Defense
Technical Reports database collection and are microfiched, it is recommended
that all reports be bound by stapling the pages together in the upper left hand
corner. All original reports shall be legible and contain original
photos/illustrations. Figures shall include figure legends and be clearly marked
with figure numbers.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 16 of 20

Section G - Contract Administration Data

ACCOUNTING AND APPROPRIATION DATA

AA: 97204002601074811930603384BPO255YP1FFKAW23RYX2331N643FFKAP1018064
AMOUNT:           $364,642.00

CLAUSES INCORPORATED BY FULL TEXT

INCREMENTAL FUNDING (MAR 1999) (USAMRAA)

a. It is estimated that the total cost to the Government for the full
performance of this contract for the period 1 January 2003 to 31 May 2007 will
be $1,640,883.00 There have been funds allotted for reimbursement of allowable
costs, and applicable fee, incurred in the performance of this contract in the
amount of only $364,642.00. It is estimated that such funded amount shall be
sufficient to cover allowable expenses for the period 1 Jan 2003 to 31 Dec 2004.
The amount of the funds currently allotted may be increased by the Contracting
Officer without further concurrence of the contractor. It is estimated that the
remaining funds will be made available in accordance with the following
schedule:
Amount                                      On or about

$413,424                                    1 January 2004
$436,376                                    1 January 2005
$426,441                                    1 January 2006

b. Pending the availability of additional funds, performance by the contractor
shall be governed by the contract clause entitled "Limitation of Funds", FAR
52.232-22.

VOUCHERS (MAR 1999) (USAMRAA)

a. The Contractor shall submit an original and one copy of public vouchers (SF
1034) not less frequently than monthly to U.S. Army Medical Research Acquisition
Activity (USAMRAA), Attn: Shelley Marken, 820 Chandler Street, Fort Detrick, MD
21702-5014 for review and forwarding for payment.

b. Voucher categories shall adhere to budget categories listed in the negotiated
budget used for funding the contract. All vouchers shall state the total amount
claimed and the subtotals claimed in the following types of categories: salaries
and wages, overhead stating percentage and base, travel, equipment, supplies,
and any other categories used in the negotiated budget. Suitable detailed
support for amounts claimed shall be shown on continuation sheets. For instance,
direct labor costs should include number of hours worked by individual, hourly
rate, and total. Travel costs should include number of trips, public carrier
rates, per diem costs, incidental costs, etc.

c. Cumulative totals of expenditures in each category shall also be shown.

d. Each voucher submitted must state the period of performance. Each voucher
submitted must request payment for only those man-hours or cost expenditures
incurred in that period.

e. The Contracting Officer shall be notified immediately in the event a budget
category is expected to deviate from the negotiated budget.

f. The completion voucher shall be submitted by the Contractor to the
Contracting Officer.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 17 of 20

TRAVEL (MAR 1999) (USAMRAA)

a. Approval of Foreign Travel. The cost of foreign travel is allowable only when
the specific written approval of the Contracting Officer or Contract Specialist
responsible for administration of the contract is obtained prior to commencing
the trip. Approval must be requested at least 30 days before the scheduled
departure date in order that all necessary clearances may be processed. Each
individual trip must be approved separately even though it may have been
included in a previously approved budget. Foreign travel is defined as any
travel outside of Canada and the United States and its territories and
possessions.
b. Domestic/local travel shall take place in accordance with Department of
Defense Joint Travel Regulations (JTR). Documentation showing dates and mileage
for such travel shall be maintained and furnished in support of invoice claiming
reimbursement.

PROPERTY REPORTING (COMMERCIAL) (MAR 1999) (USAMRAA)

The designated property administrator for Government property acquired for use
under this contract is the Contract Specialist, US Army Medical Research
Acquisition Activity, Fort Detrick, MD 21702-5014. The contractor shall furnish
the designated property administrator report, (i.e. DD FORM 1662, DOD Property
in the Custody of Contractors).
a. Interim Inventories - Annually, as of 30 September, report due 10 October,
each year.
b. Final Inventory - When the contract expires.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 18 of 20

<TABLE>

Section I - Contract Clauses

CLAUSES INCORPORATED BY REFERENCE

<S>               <C>                                                              <C>
52.202-1          Definitions                                                      DEC 2001
52.203-3          Gratuities                                                       APR 1984
52.203-5          Covenant Against Contingent Fees                                 APR 1984
52.203-6          Restrictions On Subcontractor Sales To The Government            JUL 1995
52.203-7          Anti-Kickback Procedures                                         JUL 1995
52.203-8          Cancellation, Rescission, and Recovery of Funds for Illegal or   JAN 1997
                  Improper Activity
52.203-10         Price Or Fee Adjustment For Illegal Or Improper Activity         JAN 1997
52.203-12         Limitation On Payments To Influence Certain Federal              JUN 1997
                  Transactions
52.204-4          Printed or Copied Double-Sided on Recycled Paper                 AUG 2000
52.208-8          Helium Requirement Forecast And Required Sources For             APR 2002
                  Helium
52.209-6          Protecting the Government's Interest When Subcontracting         JUL 1995
                  With Contractors Debarred, Suspended, or Proposed for
                  Debarment
52.215-2 Alt III  Audit and RJUN 1999Negotiation (Jun 1999) Alternate III
52.216-7          Allowable Cost And Payment                                       FEB 2002
52.216-11         Cost Contract--No Fee                                            APR 1984
52.222-3          Convict Labor                                                    AUG 1996
52.222-21         Prohibition Of Segregated Facilities                             FEB 1999
52.222-26         Equal Opportunity                                                APR 2002
52.223-6          Drug Free Workplace                                              MAY 2001
52.223-14         Toxic Chemical Release Reporting                                 OCT 2000
52.225-13         Restrictions on Certain Foreign Purchases                        JUL 2000
52.228-7          Insurance--Liability To Third Persons                            MAR 1996
52.232-9          Limitation On Withholding Of Payments                            APR 1984
52.232-17         Interest                                                         JUN 1996
52.232-22         Limitation Of Funds                                              APR 1984
52.232-25 Alt I   Prompt Payment (Feb 2002) Alternate I                            FEB 2002
52.232-33         Payment by Electronic Funds Transfer--Central Contractor         MAY 1999
                  Registration
52.233-1          Disputes                                                         JUL 2002
52.233-3 Alt I    Protest After Award (Aug 1996) - Alternate I                     JUN 1985
52.242-13         Bankruptcy                                                       JUL 1995
52.243-2 Alt V    Changes--Cost-Reimbursement (Aug 1987) - Alternate V             APR 1984
52.249-6          Termination (Cost Reimbursement)                                 SEP 1996
52.249-14         Excusable Delays                                                 APR 1984
52.253-1          Computer Generated Forms                                         JAN 1991
252.203-7001      Prohibition On Persons Convicted of Fraud or Other Defense-      MAR 1999
                  Contract-Related Felonies
252.204-7003      Control Of Government Personnel Work Product                     APR 1992
252.204-7004      Required Central Contractor Registration                         NOV 2001
252.209-7004      Subcontracting With Firms That Are Owned or Controlled By        MAR 1998
                  The Government of a Terrorist Country
252.225-7012      Preference For Certain Domestic Commodities                      APR 2002
252.225-7026      Reporting Of Contract Performance Outside The United             JUN 2000
                  States
252.227-7034      Patents--Subcontracts                                            APR 1984
</TABLE>

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 19 of 20

<TABLE>

<S>               <C>                                                              <C>
252.227-7039      Patents--Reporting Of Subject Inventions                         APR 1990
252.235-7011      Final Scientific or Technical Report                             SEP 1999
252.243-7001      Pricing Of Contract Modifications                                DEC 1991
252.243-7002      Requests for Equitable Adjustment                                MAR 1998
252.244-7000      Subcontracts for Commercial Items and Commercial                 MAR 2000
                  Components (DoD Contracts)
252.247-7023      Transportation of Supplies by Sea                                MAY 2002
252.247-7024      Notification Of Transportation Of Supplies By Sea                MAR 2000

</TABLE>

CLAUSES INCORPORATED BY FULL TEXT

52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force
and effect as if they were given in full text. Upon request, the Contracting
Officer will make their full text available. Also, the full text of a clause may
be accessed electronically at this/these address(es):

www.usamraa.army.mil

(End of clause)

52.252-6 AUTHORIZED DEVIATIONS IN CLAUSES (APR 1984)

(a) The use in this solicitation or contract of any Federal Acquisition
Regulation (48 CFR Chapter 1) clause with an authorized deviation is indicated
by the addition of "(DEVIATION)" after the date of the clause.

b. The use in this solicitation or contract of any Defense Federal Acquisition
Regulation Supplement (48 CFR Chapter 2) clause with an authorized deviation is
indicated by the addition of "(DEVIATION)" after the name of the regulation.

252.235-7002 ANIMAL WELFARE. (DEC 1991)

(a) The Contractor shall register its research facility with the Secretary of
Agriculture in accordance with 7 U.S.C. 2316 and 9 CFR subpart C, and 2.30, and
furnish evidence of such registration to the Contracting Officer before
beginning work under this contract.

(b) The Contractor shall acquire animals only from dealers licensed by the
Secretary of Agriculture under 7 U.S.C. 2133 and 9 CFR subpart A, 2.1 through
2.11, or from sources that are exempt from licensing under those sections.

(c) The Contractor agrees that the care and use of animals will conform with the
pertinent laws of the United States and regulations of the Department of
Agriculture (see 7 U.S.C. 2131 et. seq. and 9 CFR subchapter A, parts 1 through
4).

(d) The Contracting Officer may immediately suspend, in whole or in part, work
and further payments under this contract for failure to comply with the
requirements of paragraphs (a) through (c) of this clause.

(1) The suspension will stay in effect until the Contractor complies with the
requirements.

<PAGE>

                                                                DAMD17-03-C-0040

                                                                   Page 20 of 20

(2) Failure to complete corrective action within the time specified by the
Contracting Officer may result in termination of this contract and removal of
the Contractor's name from the list of contractors with approved Public Health
Service Welfare Assurances.

(e) The Contractor may request registration of its facility and a current
listing of licensed dealers from the Regional Office of the Animal and Plant
Health Inspection Service (APHIS), United States Department of Agriculture
(USDA), for the region in which its research facility is located. The location
of the appropriate APHIS regional office, as well as information concerning this
program may be obtained by contacting the Senior Staff Officer, Animal Care
Staff, USDA/APHIS, Federal Center Building, Hyausville, MD 20782.

(f) The Contractor shall include this clause, including this paragraph (f), in
all subcontracts involving research of live vertebrate animals.

252.235-7010 Acknowledgment of Support and Disclaimer. (MAY 1995)

(a) The Contractor shall include an acknowledgment of the Government's support
in the publication of any material based on or developed under this contract,
stated in the following terms: This material is based upon work supported by the
U.S. Army Medical Research Acquisition Activity (USAMRAA) under Contract No.
DAMD17-03-C-0040..

(b) All material, except scientific articles or papers published in scientific
journals, must, in addition to any notices or disclaimers by the Contractor,
also contain the following disclaimer: Any opinions, findings and conclusions or
recommendations expressed in this material are those of the author(s) and do not
necessarily reflect the views of the USAMRAA.Exhibit 10(ddd)

[FOUR STAR GROUP LOGO]        Four Star Group         646-872-7882
                              495 Broadway Street
                              New York, NY 10038
                              www.fourstargroup.com   elrapp@frontiernet.net

   ==========================================================================

                            MARKETING REPRESENTATION
                                    AGREEMENT

       -----------------------------------------------------------------

                            [SIGA TECHNOLOGIES LOGO]

       -----------------------------------------------------------------

                           APPLIED BACTERIAL GENOMICS

                    SIGA Technologies is applying bacterial
                    genomics in the design and development
                    of novel products for the prevention and
                    treatment of serious infectious diseases.

       -----------------------------------------------------------------

                          FOR: SIGA TECHNOLOGIES, INC.

                               420 Lexington Ave.

                               New York, NY 10170

                A DIVISION OF EXECUTIVE INTELLIGENCE NETWORK LLC.

<PAGE>

---------------------------------------------------------------------------
1.  FOUR STAR GROUP
---------------------------------------------------------------------------
---------------------------------------------------------------------------

        The bridge between the commercial and government sectors

      Marketing professionals specializing in technology, security and
intelligence.

---------------------------------------------------------------------------
The Mission
---------------------------------------------------------------------------
            o     Provide clients with a cost effective entrance into and means
                  of doing business with the US Government marketplace.

            o     Help clients better understand the Government Programming &
                  Budgeting System and the Government Acquisition Cycle.

            o     Represent clients with honesty and integrity.

            o     Provide clients with the tools and personnel necessary for
                  success in entering and understanding the Governmental
                  marketplace.

---------------------------------------------------------------------------
The Group
---------------------------------------------------------------------------
Four Star Group (FSG)

            Is a marketing consulting firm that bridges the gap between the
            commercial and government sectors. With unparalleled knowledge of
            the technology, security and intelligence industries, FSG's network
            of corporate leaders and military experts identifies and marries
            public sector business opportunities with cutting edge technologies
            developed in the private sector. By serving as the liaison between
            these two disparate worlds, FSG develops unique solutions that
            effectively address the nation's most critical information and
            security needs.

            Four Star Group, a division of Executive Intelligence Network LLC,
            was established in September 2001 in response to the increasing
            demand to integrate best of breed technologies in the interest of
            national security.

The FSG Team

            Brigadier General Richard W. Potter Jr. (USA Ret) - Director
            Government Sector

            After a distinguished thirty-five year career in the military,
            Brigadier General Richard Potter retired in 1994 from the post as
            Deputy Commanding General, United States Army Special Operations
            Command.

            Since 1995 he has provided independent consulting services
            specializing in high tech firms and companies within the defense
            industry, including Raytheon, Northrop Grumman,

            CONFIDENTIAL                PAGE 2 OF 9                    2/5/2003

<PAGE>

            Jacobs-Sverdrup, ACS Defense, GrayHawk Systems, and Arete'
            Associates. Additionally, he serves as a consultant to the Assistant
            Secretary of Defense, Command Control Communications Computers
            Intelligence (ASDC4I), the United States Special Operations Command
            (USSOCOM), United States Army Special Operations Command (USASOC),
            as well as with the Department of the Army and other government
            agencies on special projects both domestically and abroad. From
            1996-1998, General Potter served on the Defense Science Board.

            Richard Potter has been responsible for the procurement of over 500
            million dollars in government contracts.

            Cary Fields - Director Financial and Capital Markets Sector

            A renowned financial advisor, Mr. Fields holdings and influence span
            the real estate, petro-chemical, pharmaceutical, technology and
            financial industries.

            Edward Lee Rapp - Director Marketing Operations

            Mr. Rapp's operational experience in advertising (Interpublic
            Group), marketing (Zentropy Partners), technology (Arc Studios
            International) and media (WeMedia Inc.), combined with his
            successful track record as a contractor for USSOCOM and INSCOM,
            provides Four Star Group a unique bridge between commercial and
            government marketing.

Gray Hawk Systems Inc. - Team Partner

            Our partnership with Gray Hawk Systems, Inc. provides experience as
            a US Government Contractor for DoD, the US Congress, and other
            Federal Agencies. Gray Hawk also has the ability to pair technology,
            products, and services with USG Requirements as well as the ability
            to furnish a Government Defense Security Service IS-Cleared facility
            and personnel. Gray Hawk gives our clients permanent Washington DC
            presence and representation.

     The Gray Hawk Teem

            Dr. Stephen W. Drew

            Dr. Drew, a Gray Hawk consultant for this effort, is an independent
            consultant to the pharmaceutical, biotechnology and investment
            banking industries and is a member of several scientific advisory
            boards to members of these industries. Dr. Drew teaches a biological
            product design course at Princeton University and was recently the
            Astra Zeneca Visiting Fellow at Cambridge University. He retired
            from Merck & Co., Inc. in 2000, where his responsibilities included
            vice presidential positions in the Merck Manufacturing Division
            (MMD) as the VP of Vaccine Science and Technology, the VP of Vaccine
            Operations, and the VP of Technical Operations & Engineering. Prior
            to joining MMD in 1987, he was the Senior Director of Biochemical
            Engineering in the Merck Research Laboratories (MRL), a department
            that Dr. Drew started in 1981. His current scientific and technical
            interests focus on biological product design, metabolic engineering
            to achieve novel chiral synthesis of pharmaceuticals, biological
            process validation and on the integration of engineering and the
            life sciences.

            Dr. Drew received Bachelor's and Master's degrees from the
            University of Illinois and his Ph.D. from MIT. He is a member of the
            National Academy of Engineering, where he is

            CONFIDENTIAL                PAGE 3 OF 9                    2/5/2003

<PAGE>

            Chair of the Bioengineering Section. He is a member of several
            professional organizations serving interests in chemical
            engineering, chemistry and biology. He has held offices in the
            American Institute of Chemical Engineers, the American Chemical
            Society, the American Society for Microbiology, the Society for
            Industrial Microbiology, and is a Founding Fellow of the American
            Institute for Medical and Biological Engineering. He is the past
            chairman of the Advisory Committee to the Engineering Directorate of
            the National Science Foundation and has served the departments of
            chemical engineering at several universities as a member of their
            review committees.

            Thomas E. Mitchell - Vice President, Operations, Intelligence, and
            Security Division Gray Hawk Systems Inc.

            Mr. Mitchell is an accomplished business executive. A retired U.S.
            Army Colonel, Mr. Mitchell served in key leadership and management
            positions within the Special Operations Community. He currently
            manages a professional staff providing support to a variety of
            commercial and governmental organizations. Additionally, Mr.
            Mitchell lends his extensive experience as a serving member of a
            Homeland Defense Committee of the National Academy of Sciences.

            Mr. Mitchell has been responsible for the procurement and management
            of over 200 million dollars in government and commercial contracts.

            Edward F. Phillips- Division Deputy & Director, Gray hawk Systems
            Inc.

            Mr. Phillips is Director and Deputy to the Vice President of the
            Operations, Intelligence, and Security Division, responsible for
            business development and program management of division contracts.

            A former White House Staffer, Mr. Phillips served as an Intelligence
            analyst at the National Security Council and in the White House
            Situation Room during the Bush and Clinton Administrations. He was
            responsible for 8 portfolios ranging from international and domestic
            counter-narcotic and counter-terrorist operations to worldwide
            environmental issues, and was recognized as the best White House
            staff intelligence officer in the NSC by Brent Scowroft. Mr.
            Phillips holds a Master of Science degree in Management, and has
            been responsible for the procurement of over 100 million dollars of
            government contracts.

            CONFIDENTIAL                PAGE 4 OF 9                    2/5/2003

<PAGE>

---------------------------------------------------------------------------
2 Scope Of Work
---------------------------------------------------------------------------

---------------------------------------------------------------------------
To be performed for SIGA Technologies, Inc.
---------------------------------------------------------------------------

1. GENERAL DESCRIPTION AND BACKGROUND

            This Statement of Work (SOW) ("Agreement") describes the tasks
            necessary to provide SIGA Technologies, Inc. with marketing
            representation as set forth below under Phase 1 and 2.

2. OBJECTIVE

            The objective of Phase 1 is to provide SIGA Technologies, Inc.
            ("SIGA") and Four Star Group the information necessary for designing
            a successful marketing plan and product list for the penetration
            (Phases 2) of Federal, State local and the Homeland Defense markets.
            This includes identifying near term contracts and grants in addition
            to providing the necessary data for an informed gap analysis between
            potential contracts and SIGA Technologies, Inc. products.

3. TASKS

      3.1.  Manning

            The Four Star Group shall, when funded, provide SIGA personnel with
            relevant subject matter expertise to carry out all tasks, in the
            areas of Federal, State and local Governments, and private sector as
            well as connectivity for Homeland Defense.

      3.2.  Phase 1 - Research, Assessment, Evaluation and Planning

            The Four Star Group shall act as the marketing and market research
            department for SIGA Technologies, Inc. during phase one Marketing
            Assessment. In that role, the Four Star Group may in its reasonable
            judgment and in keeping with the client's objectives provide the
            following services:

           3.2.1. Conduct interviews with the client's personnel, and key
                  personnel in government agencies and potential private sector
                  partners. Including, but not limited too, visits with SIGA
                  personnel at their the labs
           3.2.2. Investigate and research the underlying science and
                  development process including safety and efficacy.
           3.2.3. Investigate and analyze various registration strategies
           3.2.4. Identify and analyze the strengths and weaknesses of
                  competitors vying for the same market space
           3.2.5. Evaluate the clients position in comparison to its
                  competition through its sources
                3.2.5.1. DoD
                3.2.5.2. FDA
                3.2.5.3. NIH
           3.2.6. Analyze product strategies, including short term market to
                  bio defense, and their impact on both the marketplace and the
                  client

            CONFIDENTIAL                PAGE 5 OF 9                    2/5/2003

<PAGE>

           3.2.7. Investigate and analyze the potential customers, market or
                  partners perception of the client
           3.2.8. Identify and reconcile the clients corporate goals
           3.2.9. Provide a "Gap Analysis" Between Clients present position and
                  its marketing goals
          3.2.10. Help create a "Second Generation" product strategy for the
                  public market
          3.2.11. Identify potential candidates for alliance or merger.
          3.2.12. Identify potential research development contracts leading
                  toward desired product
          3.2.13. Produce marketplace information releases to prepare for
                  market penetration

      3.3.  Phase 2 Marketing

            The Four Star Group shall act as the marketing and market research
            department for SIGA Technologies, Inc. during phase Two Marketing.
            In that role, the Four Star Group may in its reasonable judgment and
            in keeping with the client's objectives provide the following
            services:

           3.3.1. Respond to and align SWOT report
           3.3.2. Execute the approved strategic marketing plan
           3.3.3. Development of linked independent efforts directed to
                  maximize medical importance impact on Bio defense
           3.3.4. Produce Investor-confidence information releases to raise
                  capital market awareness
           3.3.5. Identify and endeavor to Capture relevant R&D contracts
           3.3.6. Aide in the Identification and courting of a Strategic
                  Takeover Partner

      3.4.  Recommendation

           3.4.1. Four Star Group shall make recommendations to SIGA
                  Technologies, Inc. or designated SIGA personnel regarding
                  follow-on activities identified and/or evaluated during SOW
                  execution.

      3.5.  Additional Tasks

           3.5.1. Four Star Group personnel may attend meetings, conferences,
                  and discussions as required and as provided for in 5.0 Travel
           3.5.2. In addition, Four Star Group will provide SIGA a full time
                  presence in the Washington DC area.

4. DELIVERABLES

      4.1.  At the end of Phase one FSG will provide the client with:

           4.1.1. A "SWOT" Report outlining Strengths, Weakness, Opportunities
                  and Threats.
           4.1.2. A Strategic marketing action plan (allowing for the
                  development of commercial product) to include Near, Mid, and
                  Long term sub-plans

      4.2.  Interim Progress Reports

           4.2.1. At monthly intervals FSG will provide the client with an IPR
                  outlining actions taken, tasks performed and a synopsis of
                  findings.

            CONFIDENTIAL                PAGE 6 OF 9                    2/5/2003

<PAGE>

      4.3.  Time Line

           4.3.1. The final reports for phase one are anticipated to be
                  prepared within twelve to fourteen weeks after acceptance of
                  this proposal by SIGA and receipt of funds by the Four Star
                  Group.

      4.4.  Format

            The Four Star Group shall provide deliverables in Microsoft Word
            electronic format. The deliverables shall also be provided in hard
            copy.

5. TRAVEL REQUIREMENTS

      5.1.  In support of this statement of work, Four Star Group will invoice
            SIGA for local travel within the NCA, at the approved government
            mileage rate. SIGA will fund approved travel outside the NCA. SIGA's
            project manager prior to travel execution will approve all travel
            requests. All invoices will be paid within thirty (30) days of
            dispatch or be subject to an APR of 18% and all costs and fees
            associated with collection of any unpaid invoice.

6. SIGA TECHNOLOGIES RESPONSIBILITIES

      6.1.  SIGA will provide Four Star Group with all information necessary for
            Four Star's marketing evaluation. Information to be provided to Four
            Star Group will include, but is not limited to, complete product
            specifications, financial information, manufacturing and
            producibility data, information regarding prior sales, and
            information regarding key employees. SIGA will cooperate fully with
            requests for information from Four Star Group and, upon request,
            present detailed briefings regarding any and all aspects of SIGA's
            business model and business plans, to include future product
            development plans.

7. Terms

      7.1.  The term of this agreement shall be twelve (12) months from the
            commencement of work

           7.1.1. SIGA may terminate this agreement with or without cause 6
                  (six) months after commencement, with 60 (sixty) Days prior
                  written notice. (E.g. February 1st 2003 commencement written
                  notice must be received by June 1st 2003)

           7.1.2. In the event of termination all contract and grant proposals
                  already submitted will upon award, regardless of time, count
                  towards the requirements for warrants laid out in 7.3.2 of
                  this document.

      7.2.  The cash retainer is two hundred forty nine thousand four hundred
            twenty USD ($249,420), plus all travel expenses as outlined in
            section 5.0 Travel Requirements. Payable to Executive Intelligence
            Network LLC. All work will commence upon the unconditional receipt
            of funds.

           7.2.1. Schedule of payments:

                  7.2.1.1. $35,000 (USD) Upon Signing of agreement.

                  7.2.1.2. $35,000 (USD) March 1st 2003

                  7.2.1.3. 12 equal Payments of $14,951.67 (USD) due on the
                           first of each month Commencing February 1, 2003

            CONFIDENTIAL                PAGE 7 OF 9                    2/5/2003

<PAGE>

      7.3.  Four Star Group, in consideration of discounts given, will receive

           7.3.1. Upon award to SIGA contracts or grants with a cumulative
                  value equal to $2,000,000 USD (two million) fully vested and
                  unencumbered, four Hundred thousand (400,000) warrants for
                  SIGA (NASDAQ) stock to be issued pro rata at time of award of
                  contract or grant (1 warrant per $5 of contract or grant
                  awarded) at a strike price of SIGA NASDAQ Closing price
                  January 31st 2003 with an expiration of 36 months from time of
                  issuance..

           7.3.2. Upon renewal of marketing agreement 12 months from
                  commencement of this agreement fully vested and unencumbered,
                  one hundred thousand (100,000) warrants for SIGA (NASDAQ)
                  stock at a strike price of Fair Market Value at time of
                  renewal and with an expiration of 36 months.

      7.4.  The cost of printing and distribution of all public relations
            material shall be born solely by SIGA Technologies

      7.5.  SIGA understands and agrees that the provision of any information to
            Four Star Group is solely for the purpose of an independent
            marketing evaluation, and does not guarantee that any future
            business opportunities, sales, or contracts will result from the
            work conducted by Four Star Group. SIGA will reimburse Four Star
            Group for all costs associated with due diligence and the
            development of a final report containing an analysis of the
            marketability of the products and services offered by SIGA.

8. MISCELLANEOUS

      8.1.  SIGA Technology shall not, for a period of twenty four (24) months,
            directly or indirectly, solicit or encourage any employee, agent, or
            consultant of EIN, its partners (i.e. Gray Hawk) divisions (i.e.
            Four Star Group) to leave the "employ" of EIN for any reason, nor
            shall SIGA employ such employee in its, a competing or other
            business endeavor.

      8.2.  The parties represent, warrant and acknowledge that they have
            carefully read this Agreement, they know and understand its
            contents, have consulted with an attorney of their choice, and have
            signed this Agreement of their own free will and have the authority
            to execute this document on behalf of their respective entities.

      8.3.  All notices and communications provided for hereunder shall be in
            writing and shall be mailed return receipt, or faxed or hand
            delivered to the business address of the respective party, effective
            upon deposit.

      8.4.  A party who sues under this Proposal shall pay all costs and
            reasonable attorney's fees if unsuccessful.

      8.5.  Each party agrees to waives any judicial interpretation of this
            Agreement which would create a presumption against the other as a
            result of its being the drafter of any provision of this Agreement.

      8.6.  The parties agree that all abbreviations, captions, numbering,
            headings and titles are for the convenience of the Parties and shall
            not effect the Agreement's judicial interpretation and further that
            all words and terms shall be given their English meaning as set
            forth in the latest edition of Webster's Unabridged International
            Dictionary.

      8.7.  This Agreement shall be venued, construed and interpreted in
            accordance with the laws of the State of New York.

            CONFIDENTIAL                PAGE 8 OF 9                    2/5/2003

<PAGE>

      8.8.  This Agreement constitutes the entire agreement and understanding
            between the parties, and there are no other written or oral
            representations taken into consideration in this Agreement.

Accepted for SIGA Technologies,       Accepted for Four Star Group

/s/ Thomas N. Konatich                /s/ Edward Lee Rapp
----------------------                ----------------------------
Name                                  Edward Lee Rapp

_______________________               Director Marketing Operations
Title

_______________________               February 5, 2003
Date  2/5/03

[STAMP for Thomas N. Konatich
Vice President and
Chief Financial Officer]

CONFIDENTIAL                PAGE 9 OF 9                    2/5/2003

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00050-of-00352.parquet"}]]